Jabil Inc. (JBL) Q3 2020 earnings call dated June 19, 2020
Corporate Participants:
Adam Berry — Vice President, Investor Relations
Mark T. Mondello — Chief Executive Officer & Director
Michael Dastoor — Chief Financial Officer & Executive Vice President
Analysts:
Ruplu Bhattacharya — BofA Securities — Analyst
Adam Tindle — Raymond James — Analyst
Jim Suva — Citigroup, Inc. — Analyst
Paul Chung — JPMorgan — Analyst
Steven Fox — Fox Advisors — Analyst
Shannon Cross — Cross Research — Analyst
Matt Sheerin — Stifel — Analyst
Mark Delaney — Goldman Sachs — Analyst
Robert Mueller — RBC Capital Markets — Analyst
Presentation:
Operator
Greetings and welcome to the Jabil’s Third Quarter of Fiscal Year 2020 Earnings Conference. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr. Adam Berry, Investor Relations. Thank you. You may begin.
Adam Berry — Vice President, Investor Relations
Good morning and welcome to Jabil’s third quarter of fiscal 2020 earnings call. Joining me on today’s call are Chief Executive Officer, Mark Mondello; and Chief Financial Officer, Mike Dastoor.
Please note that today’s call is being webcast live. And during our prepared remarks, we will be referencing slides. To follow along with the discussion and view the slides, you will need to be logged into our webcast on jabil.com. At the end of today’s call, both the presentation and a replay of the call will be available on Jabil’s Investor Relations website.
During today’s call, we will be making forward-looking statements, including, among other things, those regarding our outlook for our business and expected fourth quarter and fiscal ’20 net revenue and earnings. These statements are based on current expectations, forecasts and assumptions involving risks and uncertainties that could cause actual outcomes and results to differ materially. An extensive list of these risks and uncertainties are identified in our Annual Report and Form 10-K for the fiscal year ended August 31, 2019 and other filings. Jabil disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
With that, it’s my pleasure to turn the call over to Mark Mondello.
Mark T. Mondello — Chief Executive Officer & Director
Thanks, Adam. Good morning. I appreciate everyone taking time to join our call today. I’ll begin by providing a brief business update, before turning the call over to Mike, where he’ll offer details on our Q3 performance and address our guidance for the balance of the year.
So, before I get into the business at hand, I’d like to extend a warm thanks to our people here at Jabil, for their hard work and commitment, especially during these trying times.
I tend to think that successful and sustainable organizations are evaluated not only on their ability to deal with what they can control, but also on their ability to react and adapt to the environment, especially environments that shifts suddenly and shift unexpectedly. For this, I give our team high marks. Their response to COVID-19 gives me confidence and demonstrates our resiliency.
At Jabil, we help design, develop and bring to life numerous products; products that the world depends on. In many ways, this pandemic has reinforced that Jabil itself is an essential business.
If I may, I’ll now take you back to our second fiscal quarter for proper context specific to COVID. As our teams in China attempted to return from Chinese New Year, in mid-February, they were faced with travel lockdowns, quarantines and the need for social distancing. Add to this, the fact that our sites in China were operating at less than 50% capacity.
Given the ambiguity that was fast unfolding, we rescinded our financial outlook for the fiscal year. As we moved into the third quarter, COVID quickly spread, impacting regions and countries that are home to our many factories. March quickly turned into April, and April to May. And when many of us were hunkered down following stay-at-home orders, transforming kitchens or bedrooms or garages into newfound workspaces, our factories by and large continued to build and ship products.
Most importantly, throughout it all, the global incident rate of confirmed COVID cases across Jabil, remained remarkably low. I want to offer a special thanks to all of our front-line workers, those of you that work so hard in keeping our people safe, while taking amazing care of our customers directly from the factory floor. Your ability to execute and perform has been nothing short of spectacular.
And on top of it all, together, you created a COVID playbook that we use today across all sites; a playbook of protocols and best practices that we openly share with suppliers, customers, communities and competitors.
Moving on to the critical business catalyst for the quarter. We saw strong demand in Healthcare and Packaging, Cloud, Edge Devices and Mobility. In our Healthcare sector, we joined the fight against COVID, as it was simply the right thing to do. Our team is quickly transforming manufacturing lines around the world, contributing to the production of critical products such as ventilators, specialized manifolds, 3D printed components, face shields, protective masks and test kits.
In terms of our Packaging business, which serves many of the world’s top consumer brands, demand was strong in areas like cleaners and disinfectants, touchless dispensers, anti-bacterial products, and eat-at-home food products.
At the same time, Internet usage was exploding, prompted by remote learning and video conferencing. Teams from our Cloud sector along with the teams from our Mobility and Edge Device sectors were in full blown customer care mode, as end user sought digital access, their family, friends, business colleagues and patients, a trend likely to be part of the world’s new normal.
During the quarter, these areas of strength were offset by weakness in our automotive and transport and print and retail sectors. Nonetheless, our well diversified commercial portfolio allowed us to deliver $6.3 billion in revenue, in line with our expectation. To me, this is quite meaningful.
With each passing year, the blend of our revenues become better balanced and far less dependent on any single product or product family. Quite simply, greater diversification increases the reliability of our revenue.
Having said this, and as we sit here today, the impact of COVID will cost us roughly $160 million to $170 million for fiscal year ’20. Therefore, we’re taking aggressive actions to reshape the organization and ready ourselves for fiscal ’21. We’ll reduce our workforce and, in return, lower our cost structure by roughly $50 million.
I’ll now take a minute and express my appreciation for those impacted by this difficult decision, yet a decision that’s correct for the business. In taking this decision, we’ve done our very best to ensure that everyone is treated with complete respect, care and dignity.
As we make our way through the summer months, there is considerable work ahead as we prepare to host a call with investors this coming September. For lack of a better description, we look at this call as having a conversation with investors. A conversation about how Jabil management is thinking about fiscal ’21 during these uncertain times. It’s important to note that throughout this macro uncertainty, we remain steadfast in prioritizing free cash flow and expanding core operating margins.
In closing, you can be assured that we’re navigating today’s issues while being thoughtful about tomorrow’s challenges. Looking ahead, I believe our business landscape and how we choose to conduct our business may look and feel a bit different. It will possibly be more efficient; it will possibly be more optimized.
I think this is going to have real benefits as long as we don’t lose a single ounce of our customer intimacy or customer care. Also, I believe key secular trends will remain and remain in our favor. Lastly, plenty of stuff will still need to be built, and building stuff is exactly what we do.
Thank you. I’ll now hand the call over to Mike.
Michael Dastoor — Chief Financial Officer & Executive Vice President
Thanks, Mark. Good morning, everyone. Thank you for joining us today. Before I cover our Q3 financial results, I thought it would be helpful to provide a brief update on how COVID-19 has impacted our business and the end markets we serve since we last spoke on March 13.
Following our call in March, COVID-19 quickly spread across the globe. However, as Mark indicated, for most of the quarter, our operations managed to remain largely open. Our teams worked with local authorities and a large majority of our factories were deemed essential, so that we continued to build and ship products throughout Q3. In fact, since the end of March, we have largely been operating at 95% capacity despite a handful of one to two-week closures in areas like Malaysia, India and California.
Putting all together, at an enterprise level, demand largely held in Q3. However, the makeup of this demand varied extensively by end market and region as the COVID-19 outbreak and stay-at-home orders around the world impacted each in a unique way.
Let me walk you through what we’re seeing in the different end markets today. Within mobility, the out-of-seasonal launch, which began in February is going extremely well. In tandem with this, the team has also started working on the launch for our upcoming seasonal next-gen mobility products; and this too is on-track.
Moving to Edge Devices and Lifestyles. As more people work and learn from home, we’re seeing good demand for certain products, such as tablets, headphones and smart watches.
In Healthcare, we’re experiencing strong demand in the markets most critical in the fight against COVID-19: Ventilators and ventilator splitters; oxygen and temperature sensing equipment; diagnostic systems, including analyzers and test kits; and masks, ranging from protective face masks to reusable N95 masks. This strength is being offset by reduced demand for trauma and elective surgery products.
Moving to Packaging. As a reminder, our Packaging business is a supplier of the world’s leading consumer packaged goods companies. COVID-19 is exerting enormous pressure on our customers to ship unprecedented levels of cleaning and food products. Because of this, we’re seeing increasing demand in packaging for laundry products, hard surface cleaners, touchless dispensers, and antibacterial wipes. In addition, we are also seeing good demand for food packaging, spurred on by more people dining at home.
Moving to EMS. Within automotive, our near-term results and outlook have been diminished due to lower forecasted worldwide unit sales and OEM factory closures. However, looking forward, we expect weakness in the traditional automotive markets to be partly offset by additional growth in electrification, which continues to gain overall share of this market.
In semi cap, we’re seeing solid demand driven by the ongoing recovery in this end market as infrastructure spending continues. New fab plant investments are multi-year investments. And so far, customers are marching ahead with the 2020 and 2021 roadmaps.
In Wireless and 5G, consistent with prior quarters, we continue to see growth in 5G that is being offset by 4G, as the market transitions to newer technology. In the near-term, we expect 5G infrastructure rollouts to continue as network operators upgrade their services.
In Cloud, our teams are seeing an increased demand for cloud infrastructure created by stay-at-home orders around the world, which is translating to higher growth.
Moving to print and retail, we expect continued pressure in these end markets in the near term, driven mainly by office closures and stay-at-home orders.
Turning now to Industrial and Energy. Demand has been relatively consistent to-date. But moving forward, we are seeing signs of new building starts being delayed. This could have an impact on future demand.
And then finally, within the enterprise end markets, we are seeing increased demand for networking products due to work from home dynamics offset by cautious overall enterprise spend. We anticipate this demand dynamic to continue over the next few quarters.
From a cost perspective, during Q3, we incurred approximately $60 million in direct and indirect costs associated with the COVID-19 outbreak. The makeup of these costs consisted mainly of lower factory utilization due to lockdown restrictions, supply chain inefficiencies and PP&E cost to keep our people safe.
Turning now to our Q3 financial results. The combination of our ability to largely remain open, efficiently navigate sporadic factory shutdowns and the diverse nature of our end markets allowed us to deliver $6.3 billion in net revenue during the quarter, in line with internal forecasts. To me, this is a meaningful and further illustration that our diversification strategy is working.
GAAP operating income was $59 million and GAAP-diluted loss per share was $0.34. Core operating income during the quarter was $172 million. Net interest expense during the quarter came in better than expected at $49 million, due to better working capital efficiency and lower interest rates.
Oure core tax rate for the quarter was 53.7%. At the end of April, a non-U.S. entities tax incentive was extended by the government for an additional 10 years, which resulted in a revaluation of certain of those entities deferred tax assets. While this resulted in a one-time charge of $21 million in Q3, moving forward, the tax incentive extension will continue to benefit our effective tax rate for another 10 years.
Core diluted earnings per share was $0.37. It’s worth noting that the revaluation of deferred tax assets, negatively impacted our core diluted earnings per share by approximately $0.14.
Next, I’d like to call your attention to an item which impacted our GAAP results during the quarter. Over the past three years, we’ve experienced tremendous growth, adding in excess of $7 billion in revenue to our results. Importantly, the growth has been intentional and targeted at end markets that offer accretive margin and cash flow profiles.
With the success in diversifying the business, we feel it is an appropriate time, especially amidst the current economic landscape, to take steps to proactively optimize our cost structure and improve operational efficiencies.
Therefore, during Q3, we’ve taken steps to reduce our worldwide workforce. For Q3, we incurred approximately $50 million related to this, inclusive of severance costs and extended healthcare benefits to those impacted. We anticipate these costs will result in a net benefit to core operating income of $40 million to $50 million in FY ’21. This is an addition to the anticipated savings associated with the 2020 restructuring plan we announced last September.
Now, turning to our third quarter segment results. Revenue for our DMS segment was $2.4 billion, up 13% year-over-year, while core operating income for the segment increased 27% year-over-year. This resulted in core margins expanding 30 basis points to 2.9%.
Moving to EMS. Revenue for our EMS segment was $3.9 billion, down 2% year-over-year. From an end market perspective, we saw a year-over-year strength in the Cloud and semi cap space, offset by declines in automotive, print and retail. Core margins for the segment came in at 2.6%.
Turning now to our cash flows and balance sheet. As anticipated in Q3, inventory levels contracted sequentially with our days in inventory coming in at 67 days, a decline of three days quarter-over-quarter. Cash flows provided by operations were $487 million in Q3 and net capital expenditures totaled $143 million.
As a result of the strong third quarter performance in cash flow generation, adjusted free cash flow for Q3 came in stronger than expected at approximately $344 million.
It’s worth noting, while we recorded approximately $50 million of expenses in Q3, associated with the aforementioned workforce reductions, the associated cash outflow will largely be in Q4.
We exited the quarter with total debt-to-quarter EBITDA levels of approximately 1.6 times and cash balances of $763 million. During Q3, we took steps to bolster our balance sheet, adding over $625 million in liquidity, bringing our available committed capacity under the global credit facilities to $3.7 billion. With this additional capacity along with our quarter-end cash balance, Jabil ended Q3 with access to more than $4.5 billion of available liquidity, which we believe provides us ample flexibility to navigate the current market environment, all while maintaining our investment grade rating.
We repurchased approximately 800,000 shares for $21 million in Q3, bringing our total year-to-date repurchases to $190 million.
Turning now to our fourth quarter guidance, that includes approximately $45 million to $55 million in COVID-19-related costs. DMS segment revenue is expected to increase 1% on a year-over-year basis to $2.5 billion, while the EMS segment revenue is expected to decrease 8% on a year-over-year basis to $3.8 billion.
We expect total company revenue in the fourth quarter of fiscal 2020 to be in the range of $5.8 billion to $6.6 billion, for a decrease of 5% at the midpoint of the range. Core operating income is estimated to be in the range of $145 million to $245 million. Core diluted earnings per share is estimated to be in the range of $0.46 to $0.86. GAAP diluted earnings per share is expected to be in the range of $0.04 to $0.50.
Next, I’d like to outline our updated expectations for revenue in fiscal year ’20 by end market. Within DMS, today’s revenue outlook is largely unchanged. Our diversification within DMS continues to pay dividends even in the current environment. We expect core margins for DMS to be 3.8% for the fiscal year, on revenue of approximately $10.3 billion.
Turning now to EMS. With EMS, we reduced our revenue outlook for FY’20, driven by automotive, Industrial and Energy, and print and retail, which has been partly offset by continued strength in Cloud. We expect margins for EMS to be 2.6% on the year, on revenue of approximately $15.9 billion.
Putting altogether for the year, we now anticipate revenues will be $26.2 billion and core operating income to be $805 million. This outlook translates to core earnings per share of approximately $2.60 for the year. We also expect to deliver free cash flows in the range of $400 million to $450 million for the fiscal year.
Considering this outlook, to me, it’s clear that our diversification strategy continues to work and has positioned us well to navigate an incredibly challenging market environment.
In closing, I’m very proud of our Jabil team and their collective efforts over the past several months. Our early and focused efforts are working to protect the health and safety of our employees, and we continue to be vigilant and increasing our efforts in this area. I’m also very proud of the innovative ways in which Jabil’s teams have collaborated to join the global fight against COVID-19.
I’ll now turn the call over to Adam.
Adam Berry — Vice President, Investor Relations
Thanks, Mike. As we begin the Q&A session, I’d like to remind our call participants that per our customer agreements, we cannot address any customers product specific questions. We appreciate your cooperation.
Operator, we are now ready for Q&A.
Questions and Answers:
Operator
Thank you. [Operator Instructions] Our first question is coming from Ruplu Bhattacharya of Bank of America. Please go ahead.
Ruplu Bhattacharya — BofA Securities — Analyst
Hi. Thank you for taking my questions and congrats on the strong quarter and guidance. Mark, for my first question, I want to ask you about your thoughts on DMS segment seasonality. In a typical year, your November quarter or fiscal 1Q is a strong quarter for the Mobility segment given the new phone launches that happen. But if the world moves to a scenario where every year we have two main phone launches, maybe one in the May quarter or fiscal 3Q, then how should we think about the impact to DMS segment seasonality?
And also, you also have a Healthcare segment that is having strong revenues. So, at a high level, can you just help investors understand how you think about DMS revenue and margin seasonality?
Mark T. Mondello — Chief Executive Officer & Director
Sure. I think what I’d prefer to do is get into some of that detail during our discussion in September. I mentioned on the prepared remarks, even in this crazy environment, we’re going to do our best to get together with all investors in September and at least just let you know how we’re thinking about everything for fiscal ’21. On the surface today, I’d be careful not to, and I know you didn’t mean this, but for the Group, right, I’d be careful not to interchange DMS which JGP.
Our DMS business, again, is — got a number of components to it. I would — if I had to think about what we may see in September, is with the shape of our Green Point business, with the shape of Mobility, with our significant diversification inside of JGP, and then you add to it the tremendous growth we’ve had in the Healthcare, Packaging side, I would say over time that maybe some of the cyclicality you saw in the business — specific to DMS — two, three years ago, will flatten out of it.
Ruplu Bhattacharya — BofA Securities — Analyst
Okay, that makes sense. And then just for my last question, if you can talk about any component shortages that you’re still seeing? Are you being impacted in terms of being able to ship any revenues because of component shortages? Thanks.
Mark T. Mondello — Chief Executive Officer & Director
I’d characterize it this way just so you have some relativity. If, let’s say, pre-COVID — let’s say, the supply chain activity behavior pre-COVID, December/January timeframe was a 10, I think we hit our biggest dibit probably in the March/April timeframe. I call that maybe a 5 to 6. I’d say, today, we’re back to 8 or 9. And I think it stays there until we get to the backside of COVID, whenever that is.
Ruplu Bhattacharya — BofA Securities — Analyst
Great. Thank you so much and congrats again on giving guidance for the next quarter. Thank you.
Mark T. Mondello — Chief Executive Officer & Director
Yes. Thanks, Ruplu.
Operator
Thank you. Our next question is coming from Adam Tindle of Raymond James. Please go ahead.
Adam Tindle — Raymond James — Analyst
Thanks, and good morning. Mark, before the pandemic, you were thinking about just under $1 billion of non-GAAP operating income. And the new guidance looks like you’d end up just under $800 million at the midpoint. Vast majority, it seems like it’s related to COVID costs, and I wanted to dig into this.
I think you mentioned $160 million to $170 million of COVID-related costs expected for fiscal ’20. So, if you could just touch on maybe some of the nature of the costs and really how permanent these costs are? I’d imagine there’s at least a portion of that, that is non-recurring and should not impact fiscal ’21. So, any sort of breakdown between what recurs and what is more of a permanent increase to the cost structure?
Mark T. Mondello — Chief Executive Officer & Director
All right. Adam, I’ll take a shot at it. And if I don’t get it right, come back at me. So, I think pre-COVID, so — let’s take — let’s go away back to September. In September, I think we said for FY’20, we’d do $960 million in core op income. Then I think in the December call, we took that up to $980 million, if I remember correctly. And today, we’re sitting with the model. If you take the midpoint of Q4, we’re about $805 million, something like that, give or take.
So, if I go back — let’s not go back all the way to September. I don’t think that’s fair, because we took the numbers up in December. So, we go to the December number, call it $980 million. Today, we’re at $805 million. The delta is $175 million. And I think in my prepared remarks I said that COVID-related costs for the year would be $160 million, $170 million.
So, the gap between December and now, $175 million COVID-related, call it $160 million to $170 million. The rest of it is, is almost immaterial, and a bunch of puts and takes in noise.
In terms of the COVID expense specifically, we talked a little bit about this in March, when we talked about $53 million charge in February alone. I think the nice thing that is happening here is the March call we did, we had a $53 million charge to COVID, largely in partial February. So, on a monthly basis, we were — COVID was costing us $60 million, $65 million a month.
Then we move to April/May/June timeframe. I think Mike alluded to it. In Q3, COVID was about $60 million, give or take. And then I think Mike in his prepared remarks was suggesting that COVID for Q4 would be $50 million. So, the nice thing is touchwood today, trends coming down a bit. I think that has to do with the fact that we’re becoming more optimized in our process and protocols, getting people in and out of factories, by the way, with our number one objective is at all of our factories keeping them safe. And then, how those costs breakout, Adam, is we have direct costs which is largely around our protocols, temperature testing, PPE around all of our factories, very consistent to our playbook, again, protocols, processes. Then, we’ve had some disruptions in 3Q, in terms of either government shutting down factories, states shutting down factories. Where we’ve had some confirmed cases, we closed our factories until we can get testing completed. Through all that, we’re paying the idle labor. I think that’s the right thing to do in this time and place.
And then also, we’re just — that’s just the general pockets of disruption. So today, our entire factory network is running at, call it, 90%, 95%. I think revenue reflects that. But that could lead to the question of “Gee, factory network seem to be running at a normalized pace; why still the costs?” And the truth is, 3Q — and we anticipate in 4Q, we’ll still have some one-off pockets of disruption and we’ve kind of tried to handicap that as best we could for the fourth quarter.
Adam Tindle — Raymond James — Analyst
Okay, that’s helpful. It sounds like generally to summarize kind of on-track versus your initial plan at the Analyst Day, if you were to exclude the COVID costs. And I don’t want to get too far ahead. But as we think about the fiscal ’21 plan that you laid out that had that $4 EPS number, if I think about what’s going on today, you’ve got an incremental $50 million cost optimization on top of it. It seems like DMS ramp is well on-track. What would be maybe the headwinds today versus that initial $4 EPS number plan?
Mark T. Mondello — Chief Executive Officer & Director
Let’s talk about that in September. And I say that — I don’t want to be evasive, okay? But our team is a bit tired, but boy — and I talked about it in my prepared remarks intentionally. Our frontline workers are the folks at the factories, I’m always proud of our folks.
The folks we have on the factory floor today, dealing with this stuff every hour, every day, and what they’ve done, and given us the ability to — at the beginning of the year, Adam, we talked about revenue being $26 billion. In December, we took that up to like $26.5 billion, $26.7 billion. And if we — if we’re fortunate enough that the world doesn’t go completely haywire in the next 60 to 75 days and we’re close to the midpoint of guidance for 4Q, we’ll do over $26 billion this year, I think the numbers are coming in at around $26.2 billion. That’s all our people at factories who are just amazing to me, especially through all this because they are exhausted.
I think what we’ll try to do our best is, in September, and I refrained or stayed away in my prepared remarks. I forget exactly what I said, but I didn’t really call it a formal Investor Day. Because I just don’t know what the world is going to look like, neither does Mike or Adam. But we felt like it’s important in September to go beyond the normal earnings call and try to lay out for you in a very descriptive way how we see the world, and we’ll provide you a fairly comprehensive assumption set.
Man, I think — and I say this all the time. And I’ve said it for the four or five-year journey we’ve been on. The company is so diversified. And our diversification in terms of our top line, its somewhat kind of the main deal here and allowing us to hold revenue at what I think is a very-very solid level, all things considered. And again, in the most simplistic terms and you alluded to this with the opening of your question, which is, if COVID would have never occurred, I think sitting here as a leadership team, we feel very good that we would have delivered the $980 million.
Adam Tindle — Raymond James — Analyst
Makes sense. Congrats on the results despite everything going on, and thanks for the detail.
Mark T. Mondello — Chief Executive Officer & Director
Yes. Thanks, Adam.
Operator
Thank you. Our next question is coming from Jim Suva of Citigroup. Please go ahead.
Jim Suva — Citigroup, Inc. — Analyst
Thank you very much and congratulations on all the agility and hard work for your teams. Maybe a bigger strategic question. As you look at the world getting back post coronavirus, are there changes for more like localized manufacturing just from customers wanting to mitigate risk, meaning not be so concentrated in certain regions? And if so, I assume you probably have to talk about profitability. Because putting together something in St. Petersburg may have a different cost profile than putting it together in a different country and then shipping it from lowest cost, maybe a little more expensive. But can you kind of talk about, are you seeing and having discussions, and does that really impact your profitability? Thank you.
Mark T. Mondello — Chief Executive Officer & Director
Thanks, Jim. Maybe I could — could you clarify for me. So, you’re asking — are you asking are we seeing, specifically, are you saying, are we seeing people — are they moving business around, are they moving business out of China or is business moving back to the U.S.? Are you asking all of those or one of the three?
Jim Suva — Citigroup, Inc. — Analyst
Yes, kind of, just in general, are those discussions happening and are they material? Or are they — can you just kind of — because we read about the political trade wars and then we layer on a pandemic of health care on top of it. I’m just wondering if this is facilitating less of a concentrated footprint? Jabil has a very strong worldwide footprint. And if so, I assume that you have to have some discussions about costs. Just kind of overall the topic. That’s all.
Mark T. Mondello — Chief Executive Officer & Director
Okay. So, I’ll give it my best. I think — I don’t recall, I think it was the September call, where we were in this trade tariff deal that was kind of the headlines of the day and COVID took over and trade tariffs has kind of taken a backseat, at least in terms of headlines.
I believe what we said is there would be some costs — our budgeting, if you will, for FY’20 had suggested that the first half of ’20, there was cost in there, around trade tariffs, as some customers were looking to hedge China. Not a lot of customers were leaving China. In fact, as we sit today, not a lot of customers have left China. We’ve had a number of customers that have hedged China on new products. And that’s played out largely as we thought, give or take.
So, then, COVID hits. And I would say everything has been a little bit of a lock-up in terms of conversations with customers, strategically. Because customers are just trying to figure out which way is up, as are we.
So, I — if I had to think about maybe the discussion in September, that’s a little bit more strategic. I would say not a lots changed since what we said September of 2019, at the beginning of this year. I think people will be a little bit more cautious in terms of having their product built at a single site. That could be trade tariff. That could be just because — that could be because of Mother Nature concerns. I don’t know how much of that links to COVID.
The good news in all that, Jim, is, boy-oh-boy, I’m a real believer that there’s a lot of stuff that will need to be built. The few of us on the planet today that have lots of scale, have a huge advantage. I put our footprint in that for sure.
Mike talked about our balance sheet and the liquidity we have in terms of continuing to invest, and then just overall leverage our supply chain. So, as the dynamics ebb and flow, as they change, I think we’re in a reasonably good position.
Jim Suva — Citigroup, Inc. — Analyst
Thank you so much for the details, and congratulations to you and all your employees.
Mark T. Mondello — Chief Executive Officer & Director
Thanks, Jim.
Operator
Thank you. Our next question is coming from Paul Coster of JPMorgan. Please go ahead.
Paul Chung — JPMorgan — Analyst
Hi, this is Paul Chung on for Coster. Thanks for taking our questions. So, first, just on DMS; can you give us a sense for the relative strength between Healthcare, Packaging and Mobility? From your prepared remarks, they’re strengthening quite broad. But judging by your unchanged fiscal year guide for the segments, we assume Healthcare was the largest driver, which obviously makes sense. But if you could comment there and how these trends extend into 4Q? And then I have a follow-up.
Mark T. Mondello — Chief Executive Officer & Director
Okay. I would — so, I think what you asked is, is kind of a breakdown to DMS, strengths/weaknesses. I would say, tactically and maybe strategically, depending on how the whole new world order is post-COVID. Both Mike and I spoke in our prepared remarks, on; I think companies are going to do things a bit differently going forward. I’ve had the good fortune to talk to lots of our customers and their CEOs. And lots of conversation around, “Geez, are you going to travel as much? Are you going to conduct business as same?” I think our new normal as a proxy is, I don’t want to give up one inkling of — as I said in my prepared remarks — care intimacy for customers. So, I think that’s where we’ll spend our travel dollars. I think net-net our travel dollars on an annual basis will come down.
I think we’ll use more digital tools. I bring all that up, because I think when it comes to our Mobility business and our Edge Device business, and people using digital tools and working remotely for an extended period of time, I think that business will be in relatively good shape.
And then Healthcare and Packaging, both with our strategic plan around Healthcare and then we’re doing some PPE, and we’re getting a little bit of an extra boost there. I don’t remember the exact numbers. But if you, on the — for lack of better word, on the chart that we provided in September, the blue, green chart, I think we had Healthcare, Packaging for FY’19, just a little over $3 billion. And now the Healthcare, Packaging is a little over $4 billion.
And I would say, if things continue to go well for us, IT, Healthcare and Packaging, at a number of greater than $4 billion or $4.2 billion that you might see on the charts today.
Paul Chung — JPMorgan — Analyst
Got you. And then just a quick follow-up on Healthcare, specifically about elective surgeries and other products of that nature that are kind of related to COVID spurred demand. How did those products do in the quarter? And do you see ramps from maybe pent-up demand, possibly in the coming quarters? Thank you.
Mark T. Mondello — Chief Executive Officer & Director
Yes. I would say, from our observations — so, don’t take this as, again, a data point for the industry. But from our vantage point, elective surgery demand was down. I don’t think that’s any secret. I think that — but, yes, on a net-net basis, we saw strength in Healthcare.
So, what you could surmise from that is, there was a strong offset to our Healthcare business. So, elective surgery demand, down. Both PPE and other areas of our Healthcare were actually greater than the downtick we saw on elective surgeries, on a net-net basis for 3Q.
Here’s what’s interesting. I think an observation might be, geez, over time, maybe the PPE starts to fall off a little bit, how does that impact Healthcare? Again, we’ll talk about that in September. And I also believe that there is going to be a significant pent-up demand for elective surgeries, because a lot of these elective surgeries don’t go away. Just logistically, people can’t get them done in the middle of COVID.
So, the puts and takes on that are, if you look at our Healthcare, Packaging business for fiscal ’18, then you move to ’19, then you move to ’20, ’21 and ’22, I think that sector of our business is on a really good trajectory.
Paul Chung — JPMorgan — Analyst
Thank you so much.
Operator
Thank you. Our next question is coming from Steven Fox of Fox Advisors. Please go ahead.
Steven Fox — Fox Advisors — Analyst
Thank you. Good morning. Just following up on some of those comments. Mark, can you maybe step back and talk about the progress you’ve made during this period in improving the margins on some of the Healthcare programs and maybe broadly as well?
And then just as a follow-up, could you talk about some of the consumer packaging trends? You mentioned a pickup in that. I know you were sort of improving sort of the operations of that business going into the COVID pandemic. And so, is this — is there a longer-term adjustment we should think about with that business going forward? Thank you.
Mark T. Mondello — Chief Executive Officer & Director
Okay. So, in terms of margins in Healthcare, I think we talked about that in September. We talked about the addition, the wonderful strategic addition of JJMD. We gave you guys some color around that. If you go back and look at our comments in September, I think those still hold.
So, we talked about a multi-year transition with JJMD, both with top line, bottom line margins. I think that is in — tracking, likely expected in September. And I envision that — tracking that on that same path as we move to fiscal ’21 and ’22. So, net-net, I think that’s positive.
In terms of our Consumer Packaging business, Brenda, who runs that for us, has just a ton of experience. And although that business historically in the big picture of Jabil hasn’t been overly material, I think it will be not just thinking about top line, but bottom line, I think that’s a — I think that has potential to be a margin rich environment for us. And with Brenda and her team, the things they’re looking at is the stickiness and/or how to lead with technology and engineering in a market that in many ways is just simplistic molding. That’s not the area we’re playing in.
So, if I think about the trajectory of that business, I’m every bit as bullish on that, if not more than my bullishness around Healthcare. And then, Steve, in terms of margins in general, obviously margins this year have been handicapped by COVID. But I think it was Adam, who was asking the questions and prompting the discussion around, geez, topline is holding pretty good, again, proxy for our diversification.
If you can kind of handicap for the COVID costs, I think margins this year — I think at the beginning of the year, we said that last year, last couple of years margins have been 3.4%, 3.5%. I think net-net, COVID this year, if you adjust, I think this year we would have done, again, the 3.6%, 3.7%. And we’ll talk in September about how we’re thinking about the margins for ’21. And I do recognize that we have a guidepost out there of that $4 a share and 4%, but we’ll address that in another couple of months.
Steven Fox — Fox Advisors — Analyst
Great, that’s very helpful. Thank you very much.
Mark T. Mondello — Chief Executive Officer & Director
Yes. Thank you. Our next question is coming from Shannon Cross of Cross Research. Please go ahead.
Shannon Cross — Cross Research — Analyst
Thank you very much for taking my question. And you may want to address, I’m sure, some of this in September. But I’m curious, when you look at the revenue that was generated even beyond Healthcare, because you’ve talked about it significantly during the quarter from increased demand for COVID. So, whether it was some of the work from home or some of the Packaging on that.
I guess what I’m trying to understand is, what’s — the underlying businesses, were there some pockets of strength that surprised you even beyond what you saw — I don’t want to the one-timers, but obviously there has been sort of the shift and where production has been. So, I’m curious in 5G or some of the other areas, are you seeing incremental strength that’s sort of driving the fundamentals even beyond the upside that you saw from COVID? Thank you.
Mark T. Mondello — Chief Executive Officer & Director
Areas I was surprised in? I would say that around the uptick we had around COVID directly for Healthcare was probably stronger than we anticipated, if we go back to the March call. Is that sustainable? I think it’s going to be sustainable for a while. At some point, that runs its course, starts to fall off. But then, my comment about elective surgeries and things that are pent up, I think still a little bit of that, give it. So, maybe that was a little bit of a surprise.
Our Cloud business was kind of as expected. We saw good continued strength there. But that was more on the expected side. I would say the other area of surprise for us, or at least speaking for me, I don’t want to speak for the whole management team is, as I think, maybe, maybe we underestimated how broad based this digital learning, digital schools and video conferencing would be, especially when you consider COVID, and you just grossly underestimate the impact of the whole world. And I don’t think that’s going to be so temporary. So, I mentioned it in one of the responses earlier.
So, in terms of our Edge Device business, things that anything to do with where people communicating differently, I think as human beings, connection is really-really important. So, people are going to want to, whether it’s augmented reality, WebEx, Microsoft Teams, Zoom, whatever tools people are using, they’re going to want to have tools that continue to advance and allow them to have a level of really good human connection.
So, any device that has to do with that being, maybe part of the new normal. I thought — I think we saw some upside in that in 3Q. I think we’ll continue to see some strength in that in the fourth quarter. And my guess is that strength will carry on through ’21 and beyond.
Shannon Cross — Cross Research — Analyst
Thank you. And I was just curious on 3D printing technology in terms of manufacturing, are you seeing more interest in that or was it sort of a nice to have, because of the need for some of the PPE, and — that they generated? Because I know you’ve been one of the leaders in manufacturing with 3D. Thank you.
Mark T. Mondello — Chief Executive Officer & Director
I would never, as we sit today, never characterize 3D as a nice to have. I think 3D additive is finally that technology — forget about COVID — I think that technology is a secular trend in certain areas. And I think we’re going to be leaning hard into that, especially in areas of healthcare, defense and aerospace and automotive to start.
Shannon Cross — Cross Research — Analyst
Thank you.
Operator
Thank you. Our next question is coming from Matt Sheerin of Stifel. Please go ahead.
Matt Sheerin — Stifel — Analyst
Yes, thanks. Good morning and thanks for all the color so far. My question, Mark, regarding the $50 million in incremental cost cutting moves that you’ve mentioned this morning. Could you talk again about sort of the reasoning for that? Are there certain end markets within EMS or DMS that you expect just a slower growth rate and you’re adjusting? Or are there some mix issues as well?
Mark T. Mondello — Chief Executive Officer & Director
Thanks, Matt. It’s got nothing to do with any of it. So, throughout my long time at Jabil, we go through different pockets in the company where growth rates change; they’re up, they’re down. We went through a significant growth spurt, nearly doubling the size of the company over a fairly short period of time.
I think every four or five years, I think it’s important for leadership teams to really reflect on what’s worked well, what hasn’t worked well, what we can do better? Said differently, being adaptable and flexible to change. I think our org structure that we had in place the last four or five, six years, has served us really well, hence the tremendous growth.
And so, we actually started talking in our strategic discussions in the fall about, “Okay, what’s next in terms of the next three, four years in the company?” We’ve done a wonderful job diversifying our topline. We’ve made it clear to investors that our focus, we’re going to take a little bit of — a slight pause, a deep breath and focus hard on the cash flows and the margins. As such, pre-COVID, we were having lots of discussions about how to optimize the structure, how to remove any friction points in the company of this size, how to be sure that everybody has access seamlessly and quickly to all of our capabilities?
So, this was underway through the fall and into the winter. And then, COVID hit, and added to our thinking around, maybe taking some cost out of the business.
So, it’s not really a reaction. I think Mike and I both said in our prepared remarks, 3Q provided us some pockets of strength that was offset in a few pockets of weakness. This action had nothing do with any of that. It just had to do — it’s more structural in nature. It’s more permanent. I could suggest you these costs aren’t going to come back when COVID is over. And I really like how it positions the company for ’21, ’22 and beyond.
The decision point we had to make as a leadership team is, with everybody working remotely, did we think this would be a good time to go do this? Because things like this are not easy. And we made a decision to do it, because if we can do it properly and get to the other side of this with the new structure as COVID starts to clear up, think it gives us a really-really nice foundation to run the company.
Matt Sheerin — Stifel — Analyst
Okay, great. That was very helpful. And just as my follow-up, Mike, regarding the balance sheet, it looks like your inventory days were down sequentially, which is credible, certainly taking into account the supply constraints that you and your customers saw. You’re still up year-over-year. In terms of where you think that inventory is pointed directionally, do you expect to stay somewhat elevated as customers look to keep some buffer stocks, and are those supply constraints or do you see that coming down over time?
Michael Dastoor — Chief Financial Officer & Executive Vice President
So, in Q2, Matt, the inventory shot up to 70 days. I think we had some issues in China. There wasn’t anything being shipped out. So, the 70 days was unnaturally high. We’ve come down to 67 this quarter. So, progress, but not as much as I would have liked to see.
So, my target right now is. let’s get to that 60 in the medium to long term. We need to be in the mid-to-low — mid-to-high ’50s. So, that’s the eventual target. Will we get there right away, next quarter? The answer is no. But over time, I feel good that we will get there.
Matt Sheerin — Stifel — Analyst
Okay, thanks very much.
Operator
Thank you. Our next question is coming from Mark Delaney of Goldman Sachs. Please go ahead.
Mark Delaney — Goldman Sachs — Analyst
Yes, good morning. Thanks for taking the questions. First, just for me to better understand if Jabil is able to pass on any of the extra costs from COVID mitigation to customers on your existing projects? And are these costs related to COVID mitigation, factor into the pricing discussion you’re having for new business?
Mark T. Mondello — Chief Executive Officer & Director
Hey, Mark. The $160 million to $170 million for the year I spoke to, is a net cost. So, those conversations are going on all the time. Of our 400 plus relationships, 80%, 90% of those are highly strategic, long-term. And those conversations, they have analyst dimensions to them.
So, let’s just say that we’ve got a business to run. Our customers understand we have a business to run. We also want to be very-very thoughtful to all of our customers, because they’re going through tough times as well, but be rest assured that I think those discussions for the most part that have taken place during the third quarter and will continue through 4Q and into ’21, I would characterize as being very fair conversations.
Mark Delaney — Goldman Sachs — Analyst
Okay, that’s helpful. My second question, on the last earnings report, the company didn’t have enough visibility to provide guidance and there was uncertainties at that time related to both production and customer demand. And on this call, Jim already spoken at length about how the production side has improved in terms of component availability and factory utilization.
I was hoping to better understand the demand side of the equation and not so much in terms of different end markets and what you’re seeing. But just the visibility that you have into your customer demand and ordering? How much visibility has improved and how that maybe led to your comfort in being able to provide guidance as we sit today for this call? Thanks.
Mark T. Mondello — Chief Executive Officer & Director
So, let me try it this way. The processes and the tools and the analytics we used for understanding demand hasn’t changed at all. And in fact, really, I’m glad we have the tools and the analytics we have, because they’re helpful when the horizon gets a bit foggy, those tools are helpful.
I would say that — so, net-net, the visibility we have is unchanged. The issue is how much our data analytics and our resources aligned or misaligned with some customers outlooks? And I think that’s where the tools are most beneficial. Because if there is a disconnect from what we’re seeing, or we believe we should be seeing, versus the feeds that we’re getting, the demand feds. It’s driving lots of really constructive conversations. I think that there is still going to be quite a bit of choppiness in the business through the fourth quarter and into early FY’21.
I think that to have this feeling like COVID is behind us, stock market is doing great, the world is getting back on its feet, I don’t think that’s the case.
With that said, the reason we decided to give guidance for the fourth quarter is, we’ve tried our best to handicap multiple scenarios. We’ve kind of taken an average of, say, a dozen or so different scenarios and I think we have a degree of confidence that justifies the guidance for the fourth quarter.
Mark Delaney — Goldman Sachs — Analyst
Thank you.
Mark T. Mondello — Chief Executive Officer & Director
Yes, you’re welcome.
Operator
Thank you. Our next question is coming from Robert Mueller of RBC Capital Markets. Please go ahead.
Robert Mueller — RBC Capital Markets — Analyst
Hi. Can you just talk a little bit about your share repurchase and capital allocation plans? Do you plan on resuming the pace that you expected pre-COVID? And if so, by what time frame? And are there any rough targets for when you’d like to gross your authorization?
Michael Dastoor — Chief Financial Officer & Executive Vice President
So, we do have $600 million authorization out there. We’ve done about $190 million of that already, yes. We’re going to continue to be sort of thoughtful on our capital allocation, be opportunistic. I do want to balance buybacks with cash and make sure that our balance sheet is in a very strong position, which it is today.
So, the answer is, we will be looking at it opportunistically, for sure.
Robert Mueller — RBC Capital Markets — Analyst
Great. Thank you.
Operator
Thank you. At this time, I’d like to turn the floor back over to management, for any additional or closing comments.
Adam Berry — Vice President, Investor Relations
Thank you for joining us. Please reach out to us with any questions. Thank you.
Operator
[Operator Closing Remarks]